Loading...
BLOG2021-01-21T12:21:19-05:00

Recent Posts

Archives

Tags

Latest from the NCI

  • Enhertu May Be Preferred Therapy for Some Metastatic Breast CancersEnhertu May Be Preferred Therapy for Some Metastatic Breast Cancers
    In people with metastatic HER2-positive breast cancer, the targeted drug trastuzumab deruxtecan (Enhertu) markedly lengthened progression-free survival compared with trastuzumab emtansine (Kadcycla), new study results show. Read more »
  • From Scan to Scan: The Challenges of Living with Metastatic CancerFrom Scan to Scan: The Challenges of Living with Metastatic Cancer
    New treatments are helping more people with advanced or metastatic cancer live longer. At a recent NCI conference, survivors and researchers came together to discuss how to better address the needs of those living with metastatic cancer. Read more »
  • Pembrolizumab May Help Prevent Early-Stage Melanoma from ReturningPembrolizumab May Help Prevent Early-Stage Melanoma from Returning
    Trial results show patients who received the immunotherapy pembrolizumab (Keytruda) after surgery to remove high-risk stage II melanomas were less likely to have the cancer come back than those who received no treatment after surgery. Read more »
  • Combo of Ribociclib, Letrozole Improves Survival in Advanced Breast CancerCombo of Ribociclib, Letrozole Improves Survival in Advanced Breast Cancer
    In a large clinical trial, women with HR-positive, HER2-negative metastatic breast cancer treated with ribociclib (Kisqali) and letrozole (Femara) as their initial treatment lived approximately 1 year longer than women treated with letrozole only. Read more »
  • Breast Cancer Surgery Choice May Affect Young Survivors’ Quality of LifeBreast Cancer Surgery Choice May Affect Young Survivors’ Quality of Life
    Women with early-stage breast cancer who had one or both breasts surgically removed (a unilateral or bilateral mastectomy) had lower scores on a quality-of-life survey than women who had breast-conserving surgery, a new study has found. Read more »
  • Why Have Thyroid Cancer Diagnoses Spiked for US Women?Why Have Thyroid Cancer Diagnoses Spiked for US Women?
    Women are far more likely than men to be diagnosed with small thyroid cancers that probably would have never caused problems during their lifetime, a new study finds. The results may help explain why thyroid cancer seems to be more common in women. Read more »
  • Extra or Missing Chromosomes May Help Cancer Cells Survive TreatmentExtra or Missing Chromosomes May Help Cancer Cells Survive Treatment
    Aneuploidy—when cells have too many or too few chromosomes—is common in cancer cells, but scientists didn’t know why. Two new studies suggest that aneuploidy helps the cells survive treatments like chemotherapy and targeted therapies. Read more »
  • Belzutifan Approved to Treat Tumors Linked to Inherited Disorder VHLBelzutifan Approved to Treat Tumors Linked to Inherited Disorder VHL
    FDA has approved belzutifan (Welireg) to treat adults with von Hippel-Lindau disease (VHL) who have tumors of the kidney, brain, nervous system, or pancreas. The drug may help these patients avoid or delay surgery by shrinking their tumors. Read more »

CHANGE A LIFE TODAY

As long as cancer persists, none of us can truly rest. It doesn’t take much to change a life, Get in touch today and start making the difference.

Contact US
DONATE NOW
Go to Top